Literature DB >> 10738903

Breast cancer cells express cathepsins B and L but not cathepsins K or H.

O Ishibashi1, Y Mori, T Kurokawa, M Kumegawa.   

Abstract

Lysosomal cysteine proteinases (cathepsins) are considered to play a role in bone degradation mediated by metastatic breast cancers. To evaluate which cathepsin contributes to the osteolysis, we quantitatively determined the expression levels of four cathepsins in two breast cancer cell lines, MCF-7 and MDA-MB-231, by competitive RT-PCR. Cathepsin K, which is the most abundant cathepsin in osteoclasts, was not detected in either cell lines. We also failed to detect cathepsin H mRNA. By contrast, we found significant expression of cathepsins B and L in both cell lines. By Northern blot analysis cathepsin B mRNA was detected in a single form in these cells, whereas osteoclasts contained multiple forms of the mRNA. Cathepsin B protein was also detected by Western blotting as a single immunoreactive band corresponding to its mature enzyme. These findings suggest that osteolysis associated with metastatic breast cancers takes place in a different way from osteoclast-mediated bone resorption.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10738903

Source DB:  PubMed          Journal:  Cancer Biochem Biophys        ISSN: 0305-7232


  5 in total

1.  Genome-wide association study and functional analysis of feet and leg conformation traits in Nellore cattle.

Authors:  Giovana Vargas; Haroldo H R Neves; Gregório Miguel F Camargo; Vânia Cardoso; Danísio P Munari; Roberto Carvalheiro
Journal:  J Anim Sci       Date:  2018-05-04       Impact factor: 3.159

2.  Cystatin C properties crucial for uptake and inhibition of intracellular target enzymes.

Authors:  Hanna Wallin; Magnus Abrahamson; Ulf Ekström
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

3.  Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo.

Authors:  K Menzel; M Hausmann; F Obermeier; K Schreiter; N Dunger; F Bataille; W Falk; J Scholmerich; H Herfarth; G Rogler
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

4.  Methylated DNA binding domain protein 2 (MBD2) coordinately silences gene expression through activation of the microRNA hsa-mir-496 promoter in breast cancer cell line.

Authors:  Sebastian Alvarado; Joanne Wyglinski; Matthew Suderman; Stephen A Andrews; Moshe Szyf
Journal:  PLoS One       Date:  2013-10-29       Impact factor: 3.240

5.  Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis.

Authors:  Katarina Wolf; Irina Mazo; Harry Leung; Katharina Engelke; Ulrich H von Andrian; Elena I Deryugina; Alex Y Strongin; Eva-B Bröcker; Peter Friedl
Journal:  J Cell Biol       Date:  2003-01-13       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.